Literature DB >> 3860824

Immunocytochemical staining of estrogen receptor in paraffin sections of human breast cancer by use of monoclonal antibody: comparison with that in frozen sections.

A Shimada, S Kimura, K Abe, K Nagasaki, I Adachi, K Yamaguchi, M Suzuki, T Nakajima, L S Miller.   

Abstract

Estrogen receptor (ER) in human breast cancer tissues was demonstrated in paraffin sections as well as in frozen sections by immunoperoxidase methods using monoclonal antibody (H222) against ER. The avidin-biotin-peroxidase complex method was used for the paraffin sections fixed in cold buffered formalin, and the peroxidase-antiperoxidase method was used for the fixed frozen sections. The results were compared with the ER content in the respective tumor tissue determined by dextran-coated charcoal assay. The specific staining for ER was located exclusively in the nuclei of cancer cells in both paraffin and frozen sections. Differences in the intensity and distribution of nuclear staining within a section were often observed, suggesting heterogeneity of the ER content of individual breast cancer cells. In 24 breast cancer tissues studied simultaneously by both paraffin and frozen section methods, 21 (88%) showed similar evaluation of the presence of ER. The results of immunocytochemical staining agreed with those of the dextran-coated charcoal assay in 89 (82%) of the 109 paraffin-sectioned tumor tissues and in 24 (86%) of the 28 frozen-sectioned tissues, indicating that ER can be demonstrated immunocytochemically by use of paraffin as well as frozen sections.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3860824      PMCID: PMC390993          DOI: 10.1073/pnas.82.14.4803

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Current status of estrogen receptors in human breast cancer.

Authors:  W L McGuire
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Correlation between estrogen receptor protein and carcinoembryonic antigen in normal and carcinomatous human breast tissue.

Authors:  C J Menendez-Botet; J S Nisselbaum; M Fleisher; P P Rosen; A Fracchia; G Robbins; J A Urban; M K Schwartz
Journal:  Clin Chem       Date:  1976-08       Impact factor: 8.327

4.  A human cell line from a pleural effusion derived from a breast carcinoma.

Authors:  H D Soule; J Vazguez; A Long; S Albert; M Brennan
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

5.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

6.  Detection and dynamic localisation of estradiol-receptor complexes in intact target cells by immunofluorescence technique.

Authors:  I Nenci; M D Beccati; A Piffanelli; G Lanza
Journal:  J Steroid Biochem       Date:  1976 Jun-Jul       Impact factor: 4.292

7.  Pathological review of breast lesions analyzed for estrogen receptor protein.

Authors:  P P Rosen; C J Menendez-Botet; J S Nisselbaum; J A Urban; V Miké; A Fracchia; M K Schwartz
Journal:  Cancer Res       Date:  1975-11       Impact factor: 12.701

8.  Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.

Authors:  W A Knight; R B Livingston; E J Gregory; W L McGuire
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

9.  Immunocytological localization of estrogen in human mammary carcinoma cells by horseradish--anti-horseradish peroxidase complex.

Authors:  L Ghosh; B C Ghosh; T K Das Gupta
Journal:  J Surg Oncol       Date:  1978       Impact factor: 3.454

10.  Detection of estrogen binding in human mammary carcinoma by immunofluorescence: a new technic utilizing the binding hormone in a polymerized state.

Authors:  L P Pertschuk
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1976-08
View more
  24 in total

1.  The forensic value of the immunohistochemical detection of oestrogen receptors in vaginal epithelium.

Authors:  R Hausmann; M Baltzer; B Schellmann
Journal:  Int J Legal Med       Date:  1996       Impact factor: 2.686

2.  Immunohistochemical assessment of estrogen and progesterone receptors in stored imprints and cryostat sections of breast carcinomas.

Authors:  C M DeRosa; L Ozzello; D V Habif; J G Konrath; G L Greene
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

3.  Immunohistochemical analysis of breast cancer oestrogen receptor status and its correlation with oestrogen receptor biochemical assay.

Authors:  P Johnston; P Dervan; M McAllister; M J Duffy; D N Carney
Journal:  Ir J Med Sci       Date:  1988-07       Impact factor: 1.568

4.  Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer.

Authors:  W Remmele; U Hildebrand; H A Hienz; P J Klein; M Vierbuchen; L J Behnken; B Heicke; E Scheidt
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

5.  Assessment of oestrogen receptor content of breast carcinoma by immunohistochemical techniques on fixed and frozen tissue and by biochemical ligand binding assay.

Authors:  D A Paterson; C P Reid; T J Anderson; R A Hawkins
Journal:  J Clin Pathol       Date:  1990-01       Impact factor: 3.411

6.  Quantification of oestrogen receptors in breast cancer: radiochemical assay on cytosols and cryostat sections compared with semiquantitative immunocytochemical analysis.

Authors:  H M Scheres; A F De Goeij; M J Rousch; G G Hondius; D D Willebrand; A H Gijzen; F T Bosman
Journal:  J Clin Pathol       Date:  1988-06       Impact factor: 3.411

7.  Immunocytochemical staining of progesterone receptor in paraffin sections of human breast cancers.

Authors:  M Perrot-Applanat; M T Groyer-Picard; M T Vu Hai; C Pallud; F Spyratos; E Milgrom
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

8.  The discrepancy between immunocytochemical and biochemical assay of estrogen receptor in breast cancer patients treated by endocrine therapy.

Authors:  M Toi; T Nakamura; T Wada; A Yamamoto; T Toge; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1989-11

9.  Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay.

Authors:  G Saccani Jotti; S R Johnston; J Salter; S Detre; M Dowsett
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

10.  Identification of oestrogen receptors in cells of paraffin-processed breast cancers by IGSS.

Authors:  J Teasdale; P Jackson; C S Holgate; P N Cowen
Journal:  Histochemistry       Date:  1987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.